ADC Therapeutics S.A. (ADCT) ownership: Top institutional holder: Redmile Group, LLC ($58.01M). Insider activity: Net Seller (7 buys, 13 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Redmile Group, LLC | 15470502.00 | $58.01M | 2026-03-31 |
| TCG Crossover Management, LLC | 11390175.00 | $42.71M | 2026-03-31 |
| Prosight Management, LP | 8300000.00 | $31.13M | 2026-03-31 |
| BlackRock, Inc. | 6250747.00 | $23.44M | 2026-03-31 |
| EVENTIDE ASSET MANAGEMENT, LLC | 5701655.00 | $21.38M | 2026-03-31 |
| Nantahala Capital Management, LLC | 5597433.00 | $20.99M | 2026-03-31 |
| MORGAN STANLEY | 3812582.00 | $14.30M | 2026-03-31 |
| Point72 Asset Management, L.P. | 3382129.00 | $12.68M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Buy | null | 2026-06-03 | |
| Buy | null | 2026-06-03 | |
| Buy | null | 2026-06-03 | |
| Buy | null | 2026-06-03 | |
| Buy | null | 2026-06-03 | |
| Buy | null | 2026-06-03 | |
| Buy | null | 2026-06-03 | |
| Sell | null | 2026-06-01 |
Back to ADCT overview · ADCT earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.